Clinical Trials | October 09, 2022
ICON selected by BARDA to conduct anthrax vaccine clinical trial
This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.
This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.
DSCO has requested WHO to share at the earliest with CDSCO the report on establishment of causal relation to death with the medical products in question etc.
Brivaracetam is indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
This win is on the back of a prestigious order from Reliance Life Sciences
This acquisition will accelerate Medcare's plans to emerge as an international hub for health, beauty, and wellness adding to its existing network of 4 hospitals and over 20 medical centres in the UAE.
The agreement provides for acquisition of 13,50,000 equity shares of Rs. 100 each constituting 50% of the total equity share capital
The inspection concluded with no observation (FDA-483) issued.
Amantadine Extended-Release capsules had annual sales of US $2.7 million in the United States according to IQVIA data
Specialized cancer care will be offered to cancer patients making it accessible and affordable. We have adopted a patient-centric approach.
Mirabegron is indicated for the treatment of overactive bladder (OAB) with symptoms of urinary incontinence, urgency, and frequency
Subscribe To Our Newsletter & Stay Updated
